In healthy human subjects dominant genera in the lung such as Prevotella and Veillonella have been associated with changes in immune system physiology including increases in pro-inflammatory lymphocytes and cytokines and an attenuated TLR4 response in alveolar macrophages.Addi- tionally similarly to the gut microbiota members of the lung microbiota have been proposed to induce antimicrobial peptide production by the innate immune system.Studies examining the influence of the gut microbiota on the respiratory immune system via the lung-gut axis have suggested these gut organisms may influence both risk of TB infection and the development of active TB.In a study with cynologous macaques individuals were less likely to develop active TB when challenged with M. tuberculosis if they were alsoinfected with Helicobacter pylori.In contrast when mice carry the commensal bacterium Helicobacter hepaticus they are more susceptible to TB infection.While gut microbes correlate with infection risk and disease progression in these animal models understanding the molecular bases for these effects and assessing whether similar correlations exist in humans are important future challenges.Recently an association was reported between the production of serum and pulmonary short chain fatty acids SCFAs an increased abundance of anaerobes in the lung including Prevotella Veillonella and Haemophilus and a heightened risk of TB infection in humans .The mechanism underlying this association is hypothesized to be the inhibitory effect of butyrate on the induction of the pro- inflammatory cytokines IFN-g and IL-17A which are normally induced by M. tuberculosis antigens.

A. S. Liebenberg L. J. Werner L. Baxter C. Arnold K. B. Williamson C. Little F. Mansoor L. E. Naranbhai V. et al.

15 55-63.Perry S. de Jong B. C. Solnick J. V. Sanchez M. D. L. L. Yang S. Lin P. L. Hansen L. M. Talat N. Hill P. C. and HussainR.

PLoS One 612 e28991.Yilmaz B. Portugal S. Tran T. M. Gozzelino R. Ramos S. Gomes J. Regalado A. Cowan R. J. d'Apice A. J. F. Chong A. S. et al.

110 23 E2126-E2133.Hsiao A. Ahmed A. M. S. Subramanian S. Griffin N. W. Drewry L. L. Petri W. A. Jr. Haque R. Ahmed T. and Gordon J. I.

Vaccine 33 1808-1814.Segal L. N. Clemente J. C. Li Y. Ruan C. Cao J. Dancker M. Morris A. Tapyrik S. Wu B. G. Diaz P. et al.

11 7 e1004923.Segal L. N. Clemente J. C. Tsay J. J. Koralov S. B. Keller B. C. Wu B. G. Li Y. Shen N. Ghedin E. and Morris A.

37 762-792.Chang T. L. Chang C. H. Simpson D. A. Xu Q. Martin P. K. Lagenaur L. A. Schoolnik G. K. Ho D. D. Hillier S. L. Holodniy M. et al.

BMC Genomics 16 631 .Villarino N. F. LeCleir G. R. Denny J. E. Dearth S. P. Harding C. L. Sloan S. S. Gribble J. L. Campagna S. R. Wilhelm S. W. and Schmidt N. W. 2016 Composition of the gut microbiota modulates the severity of malaria.

Nature 540 280-283.Zumbrun S. D. Melton-Celsa A. R. Smith M. A. Gilbreath J. J. Merrell D. S. and O'Brien A. D. 2013 Dietary choice affects Shiga-toxin-producing Escherichia coli STEC O157H7 colonization and disease.

